You have 9 free searches left this month | for more free features.

thalidomide

Showing 1 - 25 of 271

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Pancreatic Cancer Stage IV, Chemo-induced Nausea and Vomiting Trial (Thalidomide, Nab paclitaxel, Gemcitabine)

Not yet recruiting
  • Pancreatic Cancer Stage IV
  • Chemotherapy-induced Nausea and Vomiting
  • Thalidomide
  • +2 more
  • (no location specified)
Aug 24, 2023

Transfusion-dependent Beta-Thalassemia Trial in Peshawar (Thalidomide)

Completed
  • Transfusion-dependent Beta-Thalassemia
  • Thalidomide
  • Peshawar, Khyber Pakhtunkhwa, Pakistan
    Blood Care Clinic
Nov 19, 2023

Brain and CNS Tumors Trial in Chicago (thalidomide, topotecan HCl)

Terminated
  • Brain and Central Nervous System Tumors
  • thalidomide
  • topotecan hydrochloride
  • Chicago, Illinois
    Rush Cancer Institute at Rush University Medical Center
Jan 5, 2023

Mantle Cell Lymphoma, Non-Hodgkin's Lymphoma Trial in Miami (Thalidomide)

Active, not recruiting
  • Mantle Cell Lymphoma
  • Non-Hodgkin's Lymphoma
  • Thalidomide
  • Miami, Florida
    University of Miami
Sep 14, 2022

Multiple Myeloma and Plasma Cell Tumor Trial in Buffalo (dexamethasone, doxorubicin HCl, thalidomide)

Completed
  • Multiple Myeloma and Plasma Cell Neoplasm
  • Buffalo, New York
    Roswell Park Cancer Institute
Sep 30, 2022

Myelofibrosis Trial in United States (Ruxolitinib, Thalidomide)

Active, not recruiting
  • Myelofibrosis
  • Middletown, New Jersey
  • +6 more
Aug 23, 2022

Chronic Lymphocytic Leukemia Trial in New York (thalidomide, lenalidomide, rituximab)

Completed
  • Chronic Lymphocytic Leukemia
  • thalidomide
  • +2 more
  • New York, New York
    Weill Cornell Medical College
Dec 23, 2021

Metastatic Colorectal Cancer Trial in Fuzhou (Thalidomide, TAS-102)

Recruiting
  • Metastatic Colorectal Cancer
  • Fuzhou, Fujian, China
  • +5 more
Mar 4, 2022

Multiple Myeloma Trial in Shanghai (Selinexor, Thalidomide, Lenalidomide)

Recruiting
  • Multiple Myeloma
  • Shanghai, Shanghai, China
    Shanghai Changzheng Hospital
Mar 3, 2022

HIV Trial in United States (Thalidomide)

Completed
  • HIV Infections
  • Thalidomide
  • Aurora, Colorado
  • +5 more
Oct 27, 2021

Brain and CNS Tumors Trial in United States (procarbazine HCl, thalidomide)

Completed
  • Brain and Central Nervous System Tumors
  • procarbazine hydrochloride
  • thalidomide
  • Decatur, Illinois
  • +4 more
Sep 7, 2021

Plasma Cell Myeloma, Renal Failure Trial in Atlanta (Bortezomib, Daratumumab, Dexamethasone)

Recruiting
  • Plasma Cell Myeloma
  • Renal Failure
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Jun 13, 2022

Lung Cancer Trial in United States (carboplatin, irinotecan HCl, thalidomide)

Completed
  • Lung Cancer
  • Decatur, Illinois
  • +4 more
Sep 7, 2021

Multiple Myeloma and Plasma Cell Tumor, Neurotoxicity Trial in Duarte (drug, genetic, other, procedure)

Completed
  • Multiple Myeloma and Plasma Cell Neoplasm
  • Neurotoxicity
  • Duarte, California
    City of Hope Medical Center
Aug 17, 2021

Brain and CNS Tumors, Solid Tumor Trial in United States (temozolomide, thalidomide, radiation therapy)

Completed
  • Brain and Central Nervous System Tumors
  • Unspecified Adult Solid Tumor, Protocol Specific
  • Decatur, Illinois
  • +4 more
Sep 7, 2021

Multiple Myeloma Trial in Chengdu (Selinexor, Thalidomide, Dexamethasone)

Not yet recruiting
  • Multiple Myeloma
  • Chengdu, Sichuan, China
    West China Hospital of Sichuan University
May 13, 2021

Systemic Lupus Erythematosus (SLE), Juvenile SLE, Cutaneous Lupus Trial in São Paulo (Thalidomide, Hydroxychloroquine reduced,

Completed
  • Systemic Lupus Erythematosus (SLE)
  • +2 more
  • Thalidomide
  • +2 more
  • São Paulo, Brazil
    Hospital das Clinicas da Faculdade de Medicina da USP
Dec 15, 2021

Multiple Myeloma, Chronic Kidney Disease Trial in United Kingdom (Bortezomib, Thalidomide, Bendamustine)

Completed
  • Multiple Myeloma
  • Chronic Kidney Disease
  • Basingstoke, United Kingdom
  • +8 more
Jan 26, 2022

Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type Trial in Guangzhou (pegaspargase, Gemcitabine, Oxaliplatin)

Recruiting
  • Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type
  • Guangzhou, Guangdong, China
    Department of Medical Oncology, Sun Yat-sen University Cancer Ce
Mar 12, 2021

Brain and CNS Tumors, Glioblastoma Multiforme Trial in United States (Celecoxib, Isotretinoin, Temozolomide)

Completed
  • Brain and Central Nervous System Tumors
  • Glioblastoma Multiforme
  • Fort Smith, Arkansas
  • +11 more
Sep 21, 2021

Chronic Radiation Proctitis Trial (Thalidomide)

Unknown status
  • Chronic Radiation Proctitis
  • Thalidomide
  • (no location specified)
Dec 19, 2020

Multiple Myeloma Trial in Little Rock (Carfilzomib, Thalidomide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Little Rock, Arkansas
    University of Arkansas for Medical Sciences
Sep 1, 2022

Amyloidosis Trial in United Kingdom (Carfilzomib, Thalidomide, Dexamethasone)

Completed
  • Amyloidosis
  • Plymouth, Devon, United Kingdom
  • +13 more
Mar 18, 2021

Tumors Metastatic to Brain Trial in Philadelphia (radiation, drug, procedure)

Completed
  • Tumors Metastatic to Brain
  • radiation therapy
  • +2 more
  • Philadelphia, Pennsylvania
    Radiation Therapy Oncology Group
Oct 29, 2020

Multiple Myeloma Trial in Worldwide (Velcade (Bortezomib), Thalidomide, Dexamethasone)

Terminated
  • Multiple Myeloma
  • Velcade (Bortezomib)
  • +2 more
  • Graz, Austria
  • +80 more
Sep 21, 2021